Market Size of Muscle Stimulator Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 3.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Muscle Stimulator Market Analysis
The Muscle Stimulator Market is projected to register a CAGR of 3.5% during the forecast period.
The pandemic had a mild impact on the market as many respiratory muscle stimulators were launched, which were used to treat patients with COVID-19. For instance, Liberate Medical's VentFree Respiratory Muscle Stimulator received United States Food and Drug Administration emergency approval during the early pandemic. The device delivers stimulation in a non-invasive fashion, and the therapy can be initiated immediately at the start of ventilation and continued until patients are weaned off ventilation. Thus, COVID-19 has had a mild impact on the growth of the market. However, as the pandemic has currently subsided, the studied market is expected to have normal growth during the forecast period of the study.
Moreover, factors such as unhealthy diets and lack of fitness activities among the population result in musculoskeletal disorders, leading to market growth. The incidence of these disorders increases as the geriatric population is at more risk, and their number is drastically increasing.
For instance. according to the United Nations World Population Prospects 2022, the share of the global population aged 65 years or above is projected to rise from 10 percent in 2022 to 16 percent in 2050. The source also stated that by 2050, the number of persons aged 65 years or over worldwide is projected to be more than twice the number of children under age 5 and about the same as the number of children under age 12. Since the older population is prone to neuromuscular diseases, it is expected to generate the need for muscle stimulator devices for treatment, thereby driving the market's growth.
Moreover, according to an article published by the Journal of Family Medicine and Primary Care in June 2022, musculoskeletal disorders constitute 1,194 prevalent cases per 100,000 among children aged 5 to 19 years in India every year. Hence, the high prevalence of musculoskeletal disorders among children in India is expected to drive the adoption of muscle stimulators for treatment, which drives the growth of the studied market.
Furthermore, the launch of several technologically advanced products is boosting the market growth. For instance, in In December 2021, CUTERA, INC., announced the launch of the next generation of truSculpt flex. The new truSculpt flex+ rapid treatment mode takes Cutera's proprietary Multi-Directional Stimulation to the next level offering the same toning, firming and strengthening results in a fraction of the treatment time.
Thus, the abovementioned factors such as the rising prevalence of neuromuscular disorders coupled with the increasing geriatric population, and the rising product launches are expected to boost the market growth. However, the presence of cos-efficient alternative therapies, and stringent regulatory policies and safety concerns are expected to hinder market growth.
